ISBT 128
ISBT 128 is a global standard for the identification, labeling, and information processing of human blood, tissue, and cell products across international borders and health care systems. It is used by more than 80 countries and is endorsed by the World Health Organization (WHO) and the International Society of Blood Transfusion (ISBT).
Overview[edit | edit source]
ISBT 128 is a system designed to ensure the highest levels of accuracy, safety, and efficiency for patients, donors, and healthcare professionals. It uses a unique numeric identifier for each product, which can be barcoded for easy scanning and tracking. This identifier includes information about the product's origin, type, and characteristics.
History[edit | edit source]
The ISBT 128 standard was developed by the International Council for Commonality in Blood Banking Automation (ICCBBA), a non-profit organization dedicated to improving safety and efficiency in the field of transfusion medicine. The standard was first published in 1994 and has been updated regularly since then to incorporate new technologies and practices.
Implementation[edit | edit source]
Implementing ISBT 128 requires a comprehensive approach that includes changes to labeling practices, information systems, and staff training. The ICCBBA provides detailed implementation guides and other resources to assist organizations in this process.
Benefits[edit | edit source]
The use of ISBT 128 can bring a number of benefits, including improved patient safety, increased efficiency, and enhanced traceability of blood, tissue, and cell products. It can also facilitate international exchange and compatibility of products.
See also[edit | edit source]
- Blood transfusion
- Tissue transplantation
- Cell therapy
- International Council for Commonality in Blood Banking Automation
References[edit | edit source]
ISBT 128 Resources | ||
---|---|---|
|
|
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD